These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9819383

  • 21. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
    Leventaki V, Drakos E, Medeiros LJ, Lim MS, Elenitoba-Johnson KS, Claret FX, Rassidakis GZ.
    Blood; 2007 Sep 01; 110(5):1621-30. PubMed ID: 17416736
    [Abstract] [Full Text] [Related]

  • 22. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.
    Nieborowska-Skorska M, Slupianek A, Xue L, Zhang Q, Raghunath PN, Hoser G, Wasik MA, Morris SW, Skorski T.
    Cancer Res; 2001 Sep 01; 61(17):6517-23. PubMed ID: 11522649
    [Abstract] [Full Text] [Related]

  • 23. Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.
    Colomba A, Courilleau D, Ramel D, Billadeau DD, Espinos E, Delsol G, Payrastre B, Gaits-Iacovoni F.
    Oncogene; 2008 Apr 24; 27(19):2728-36. PubMed ID: 17998938
    [Abstract] [Full Text] [Related]

  • 24. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M.
    Blood; 1995 Sep 15; 86(6):2321-8. PubMed ID: 7662979
    [Abstract] [Full Text] [Related]

  • 25. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1).
    Turturro F, Frist AY, Arnold MD, Seth P, Pulford K.
    Oncogene; 2001 Jul 27; 20(33):4466-75. PubMed ID: 11494142
    [Abstract] [Full Text] [Related]

  • 26. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
    Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY.
    Blood; 1997 Feb 15; 89(4):1394-404. PubMed ID: 9028963
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a.
    Gu TL, Tothova Z, Scheijen B, Griffin JD, Gilliland DG, Sternberg DW.
    Blood; 2004 Jun 15; 103(12):4622-9. PubMed ID: 14962911
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.
    Ambrogio C, Voena C, Manazza AD, Piva R, Riera L, Barberis L, Costa C, Tarone G, Defilippi P, Hirsch E, Boeri Erba E, Mohammed S, Jensen ON, Palestro G, Inghirami G, Chiarle R.
    Blood; 2005 Dec 01; 106(12):3907-16. PubMed ID: 16105984
    [Abstract] [Full Text] [Related]

  • 33. Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase.
    Tartari CJ, Gunby RH, Coluccia AM, Sottocornola R, Cimbro B, Scapozza L, Donella-Deana A, Pinna LA, Gambacorti-Passerini C.
    J Biol Chem; 2008 Feb 15; 283(7):3743-50. PubMed ID: 18070884
    [Abstract] [Full Text] [Related]

  • 34. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
    Werner MT, Zhao C, Zhang Q, Wasik MA.
    Blood; 2017 Feb 16; 129(7):823-831. PubMed ID: 27879258
    [Abstract] [Full Text] [Related]

  • 35. SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling.
    Honorat JF, Ragab A, Lamant L, Delsol G, Ragab-Thomas J.
    Blood; 2006 May 15; 107(10):4130-8. PubMed ID: 16469875
    [Abstract] [Full Text] [Related]

  • 36. Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type I insulin-like growth factor receptor.
    Shi B, Vishwamitra D, Granda JG, Whitton T, Shi P, Amin HM.
    Neoplasia; 2013 Jun 15; 15(6):669-83. PubMed ID: 23730215
    [Abstract] [Full Text] [Related]

  • 37. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F, Medeiros LJ, Leventaki V, Atwell C, Cho-Vega JH, Tian L, Claret FX, Rassidakis GZ.
    Cancer Res; 2006 Jul 01; 66(13):6589-97. PubMed ID: 16818631
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B, DeBell KE, Graham L, Rellahan BL, Alava MA, Laborda J, Bonvini E.
    J Immunol; 1998 Feb 01; 160(3):1059-66. PubMed ID: 9570517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.